




Searching News Database: human embryonic stem cell
HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
HSMN NewsFeed - 29 Jul 2008
ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
HSMN NewsFeed - 25 Jan 2008
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
HSMN NewsFeed - 1 Aug 2007
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
HSMN NewsFeed - 5 Mar 2007
Stem Cell Innovations Names Ian Lyons, Ph.D., U.S. Chief Scientific Officer
Stem Cell Innovations Names Ian Lyons, Ph.D., U.S. Chief Scientific Officer
HSMN NewsFeed - 17 Jan 2007
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
HSMN NewsFeed - 6 Nov 2006
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
HSMN NewsFeed - 22 Jun 2006
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
HSMN NewsFeed - 18 May 2006
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Additional items found! 25

Members Archive contains
25 additional stories matching:
human embryonic stem cell
(Password required)
human embryonic stem cell
(Password required)